M&A Deal Summary |
|
|---|---|
| Date | 2016-03-15 |
| Target | Putney |
| Sector | Life Science |
| Buyer(s) | Dechra Pharmaceuticals |
| Sellers(s) | NewSpring Capital |
| Deal Type | Add-on Acquisition |
| Deal Value | 200M USD |
| Advisor(s) | Jefferies (Financial) Latham & Watkins (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1997 |
| Sector | Life Science |
| Revenue | 682M GBP (2022) |
Dechra Pharmaceuticals is an international specialist in veterinary pharmaceuticals and related products business. Its expertise is in the development, manufacturing, sales, and marketing of quality products exclusively for veterinarians worldwide. The company's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Dechra Pharmaceuticals was founded in 1998 and is based in Northwich, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 11 of 15 |
| Sector (Life Science) | 10 of 13 |
| Type (Add-on Acquisition) | 9 of 13 |
| State (Maine) | 1 of 1 |
| Country (United States) | 3 of 4 |
| Year (2016) | 2 of 3 |
| Size (of disclosed) | 1 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-14 |
Laboratorios Brovel S.A. de C.V.
Mexico City, Mexico Laboratorios Brovel S.A. de C.V. is a veterinary pharmaceuticals company. |
Buy | £4M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-09-16 |
Apex Laboratories Pty
Somersby, Australia Apex Laboratories Pty Ltd. is a pharmaceutical company which manufactures, markets and sells branded non-proprietary prescription and other related companion animal products in Australia and New Zealand. |
Buy | AU$55M |
| Category | Private Equity Firm |
|---|---|
| Founded | 1999 |
| PE ASSETS | 1.7B USD |
| Size | Large |
| Type | Sector Agnostic |
NewSpring Capital is a private investment firm focused on growth companies in the Mid-Atlantic US. The Firm can provide both growth equity and junior capital to prospective companies. NewSpring's target investment size for both mezzanine and equity financing is $2 to $5 million, although for new ventures, the Firm can commit up to $10 million. Sectors of interest include specialty manufacturing, technology, business services, information technology, life science, healthcare services, and medical devices. NewSpring Capital was formed in 1999 and is based in Radnor, Pennsylvania with an additional office in Short Hills, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 36 of 81 |
| Sector (Life Science) | 5 of 6 |
| Type (Add-on Acquisition) | 19 of 45 |
| State (Maine) | 1 of 1 |
| Country (United States) | 35 of 80 |
| Year (2016) | 1 of 5 |
| Size (of disclosed) | 9 of 16 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-03-08 |
Celigo
San Mateo, California, United States Celigo is an integration platform as a service (iPaaS) that allows IT and line of business teams alike to automate both common and custom business processes, enabling the entire organization to be more agile and innovate faster than competitors. Celigo was formed in 2011 and is based in San Mateo, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-03-29 |
South Moon Under
Annapolis, Maryland, United States South Moon Under is a provider of an eclectic mix of men's and women's clothing, swimwear, accessories, jewelry, and gifts for the home. South Moon Under was founded in 1968 and is based in Annapolis, Maryland. |
Buy | - |
